{"nct_id":"NCT03040973","title":"Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2017-07-04","start_date_type":"ACTUAL","primary_completion_date":"2027-07-30","primary_completion_date_type":"ESTIMATED","completion_date":"2027-07-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NVS"]}